The estimated Net Worth of Ramy A Mahmoud is at least $3.08 Milione dollars as of 17 July 2024. Ramy Mahmoud owns over 111,426 units of OptiNose Inc stock worth over $1,110,420 and over the last 7 years he sold OPTN stock worth over $535,704. In addition, he makes $1,437,940 as President e Chief Operating Officer at OptiNose Inc.
Ramy has made over 21 trades of the OptiNose Inc stock since 2020, according to the Form 4 filled with the SEC. Most recently he sold 111,426 units of OPTN stock worth $127,026 on 17 July 2024.
The largest trade he's ever made was exercising 255,427 units of OptiNose Inc stock on 23 November 2020 worth over $416,346. On average, Ramy trades about 25,903 units every 48 days since 2017. As of 17 July 2024 he still owns at least 1,206,978 units of OptiNose Inc stock.
You can see the complete history of Ramy Mahmoud stock trades at the bottom of the page.
DR. Ramy A. Mahmoud M.D. serves as President, Chief Operating Officer of the Company. Dr. Mahmoud has served as our President and Chief Operating Officer since 2010. Prior to joining us, Dr. Mahmoud spent 14 years at Johnson & Johnson, where he served as Chief Medical Officer and a member of the Global Management Board of the Ethicon group of companies. During his tenure at Johnson & Johnson, he also held senior roles in the pharmaceutical sector. Dr. Mahmoud served for 10 years on active duty in the U.S. Army and an additional 10 years in the Army Reserves, achieving the rank of Lieutenant Colonel. During his military service, Dr. Mahmoud held various patient care, research, and academic positions, culminating in his position as the head of the Department of Epidemiology at the Walter Reed Army Institute of Research. He has published more than 50 peer-reviewed papers and textbook chapters, and has served as a scientific reviewer for a number of journals and textbooks. Dr. Mahmoud earned a Master of Healthcare Management and Policy degree from the Harvard School of Public Health and an M.D. from the University of Miami. He has earned board certification in both Public Health/Preventive Medicine and in Internal Medicine.
As the President e Chief Operating Officer of OptiNose Inc, the total compensation of Ramy Mahmoud at OptiNose Inc is $1,437,940. There are 1 executives at OptiNose Inc getting paid more, with Peter Miller having the highest compensation of $2,033,500.
Ramy Mahmoud is 55, he's been the President e Chief Operating Officer of OptiNose Inc since 2010. There are 9 older and 7 younger executives at OptiNose Inc. The oldest executive at OptiNose Inc is Sandra Helton, 70, who is the Independent Director.
Ramy's mailing address filed with the SEC is C/O OPTINOSE, INC., 777 TOWNSHIP LINE ROAD, SUITE 300, YARDLEY, PA, 19067.
Over the last 19 years, insiders at OptiNose Inc have traded over $144,654,703 worth of OptiNose Inc stock and bought 116,688 units worth $814,936 . The most active insiders traders include Sriram Venkataraman, Capital Partners Ii Gp, Llc... e Rajat Rai. On average, OptiNose Inc executives and independent directors trade stock every 26 days with the average trade being worth of $106,645. The most recent stock trade was executed by Anthony J Krick on 17 July 2024, trading 6,845 units of OPTN stock currently worth $7,803.
optinose, inc., established in 2010 and headquartered in yardley, pennsylvania, is a publicly traded, global specialty pharmaceutical company focused on serving the needs of patients cared for by ent and allergy specialists. our team of kind, passionate, innovative people is building a new kind of organization without the encumbrances of a company with legacy systems and beliefs. we are unified by a shared mission: to improve lives. we do this while also creating great value for the healthcare system and great outcomes for our stakeholders. as innovators in every aspect of our work, we pursue faster and less costly product development, explore evolving commercial business models, and actively seek innovative ways to be more effective and efficient in all areas of the business. we operate with an overarching commitment to doing what is right. we are committed to working together as a team that chooses to live every day by core company values that guide our daily behaviors, creating a fo
OptiNose Inc executives and other stock owners filed with the SEC include: